BOM Capital invests in Gilde Healthcare
We advised BOM Capital with its investment in Gilde Healthcare IV, an investment fund investing in innovative medical technology companies, digital health and therapeutics in Europe and the US.
LSP invests in ViCentra
We advised LSP (Life Sciences Partners) with its investment in the Series B financing round of ViCentra, a company developing and commercializing an insulin pump system for diabetes patients. With its Kaleido insulin pump, ViCentra aims to reduce the impact that diabetes can have on daily life. The syndicate, led by LSP with participation from existing investor INKEF, will invest EUR 10 million. The funding will support European commercialization of the Kaleido system and preparations for US market entry.
BOM Capital invests in Endeit Capital
We advised BOM Capital with its investment in Endeit Fund II, an investment fund providing growth equity to European internet technology companies.
Stichting DOEN invests in Zeewaar
We advised Stichting DOEN with its investment in Zeewaar, a company that farms seaweed and produces and sells seaweed products.
BOM Capital invests in Aglaia Biomedical Ventures
We advised BOM Capital with its investment in Aglaia Oncology Fund II, an investment fund focusing on biomedical companies in the field of oncology.
Stichting DOEN invests in Nederland Isoleert
We advised Stichting DOEN with its investment in Nederland Isoleert, a company that provides isolation for homes in the Netherlands by way of collective purchasing.
Stichting DOEN invests in Chocolatemakers
We advised Stichting DOEN with its investment in Chocolatemakers, manufacturers of sustainable chocolate located in Amsterdam.
Mendix
Mendix (App Platform as a Service (aPaaS)) secured a venture loan provided by Silicon Valley Bank (SVB) and related security. The transaction included a warrant. *
* Marcel van de Vorst led this transaction for Mendix whilst at previous law firm.
Forcare
Forcare, a developer of a software suite that seamlessly integrates existing healthcare systems, has acquired a growth capital financing from Prime Ventures. We advised Prime Ventures. *
* Marcel van de Vorst led this transaction whilst at previous law firm.